遠隔患者モニタリング (RPM) 市場 – 2030年までの世界予測

Report Overview

The global remote patient monitoring market is projected to reach USD 56.94 billion by 2030 from 27.72 billion in 2024, at a CAGR of 12.7% from 2024 to 2030.

世界の遠隔患者モニタリング市場は、2024 年の 277 億 2000 万米ドルから 2030 年までに 569 億 4000 万米ドルに達し、2024 年から 2030 年までの CAGR は 12.7% になると予測されています。

Reason for growth in the remote patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death in hospitals, hence the solutions that monitor patients remotely have been necessary in the prevention and management of risks. Further, the incidence of chronic diseases such as cardiovascular diseases, obesity, and diabetes is rising, which in turn increases the demand for effective remote monitoring technologies. The cost of healthcare in the US has substantially deteriorated; almost half of US adults are struggling to afford prescription drugs and doctor visits. This affordability issue challenges patients to use remote patient monitoring technologies since they are experiencing difficulties coming up with money for basic healthcare services, not to mention coming up with money for new digital tools.

遠隔患者モニタリング市場の成長の理由：血流感染、尿路感染、肺炎、C.ディフィシルによる感染症などの院内感染（HAI）にかかる人が増えています。これらの感染症は重篤な健康合併症や病院での死亡に関連しているため、リスクの予防と管理には患者を遠隔監視するソリューションが必要でした。さらに、心血管疾患、肥満、糖尿病などの慢性疾患の発生率が増加しており、効果的な遠隔監視技術の需要が高まっています。米国の医療費は大幅に悪化しています。米国の成人のほぼ半数は、処方薬や医師の診察を支払うのに苦労しています。この手頃な価格の問題により、患者は新しいデジタルツールの資金を捻出するのはもちろんのこと、基本的な医療サービスの資金を捻出することも困難になっているため、遠隔患者モニタリングテクノロジーの使用が困難になっています。

“Cloud based deployment is the fastest segment in the remote patient monitoring software by deployment market in 2023”

Cloud-based deployment is expected to be the fastest-growing segment in the remote patient monitoring market during 2023, mainly because this model has several advantages, such as easy integration of data from multiple cloud sources, unlimited access by users from remote locations, low maintenance costs, high security and privacy, easy access, no need to buy hardware up front, and excellent flexibility in the use of capacity and resources. A plethora of applications made accessible through the cloud-based model with core functionalities involving accounting, performance management, and also webmails and instant messages are all proving to be helpful in fueling this particular portion.

“North America dominated the remote patient monitoring market in 2023.”

The remote patient monitoring market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The North American region dominated the remote patient monitoring market because of several factors such as substantially high adoption rates of healthcare technologies, a robust and well-established infrastructure in healthcare, and constant growth in healthcare spending that supports such progress. In addition, the increasing trend in the chronic diseases patients suffer from and the increasing need for home healthcare solutions will also increase growth in this region’s market. According to the Department of Health and Human Services’ Office of Inspector General report, that Medicare enrolees receiving RPM increased more than 10-fold from 55,000 in 2019 to 570,000 in 2022, indicating a substantial increase in adoption.

The break-down of primary participants is as mentioned below:

• By Company Type – Tier 1: 40%, Tier 2: 35%, and Tier 3: 25%
• By Designation – C-level: 35%, Director-level: 40%, and Others: 25%
• By Region – North America: 45%, Europe: 30%, Asia Pacific: 20%, Latin America: 3%, and Middle East & Africa: 2%.

Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Oracle (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), Siemens Healthineers AG (Germany), Baxter (US), Biobeat (Israel), Biotronik (Germany), and VitalConnect (US) are some of the key players in the remote patient monitoring market.

• The study includes an in-depth competitive analysis of these key players in the remote patient monitoring market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the remote patient monitoring market by component (devices by function [cardiac monitoring devices, neurological monitoring devices, respiratory monitoring devices, blood glucose monitoring devices, fetal & neonatal monitoring devices, weight monitoring devices, multiparameter monitoring devices, pulse oximeter devices, thermometers, other monitoring devices (rehabilitation and physical therapy devices, fall detection devices, and others)], by product type- [wearable devices, implantable devices, handheld & portable devices, others (stationary devices, and others)], software by deployment- [on-premise model and cloud-based model], by transmission type- [synchronous and asynchronous], and services). By indication (oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement (weight management, fitness monitoring, hydration monitoring, nutritional tracking & monitoring, etc), mental health, and others (obstetrics & gynecology, immunology, infectious diseases, metabolic disorders, ophthalmology, gastroenterology, nephrology & urology, hematology, endocrinology, musculoskeletal disorders, and others)). By end user (healthcare providers [hospitals, ambulatory surgical centers, ambulatory care centers, and other outpatient settings, long term care & assisted living facilities, home healthcare, and other healthcare providers (diagnostics & imagining centers, rehabilitation centers, behavioural health centers, and others)], healthcare payers, patients, pharmaceutical & biotechnology companies, medTech companies, and other end users (employer groups, government organizations, academic institutes, research centers, and others)), and by region (North America, Europe, Asia Pacific, Latin America, and Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the remote patient monitoring market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; partnerships, agreements. new product & service launches, regulatory approval, investment, fundings, mergers and acquisitions, and recent developments associated with the remote patient monitoring market. Competitive analysis of upcoming startups in the remote patient monitoring market ecosystem is covered in this report.

Reasons to buy this report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the remote patient monitoring market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• Analysis of key drivers (transforming patient care through digital innovation, telehealth driving growth in remote patient monitoring, rising prevalence of chronic diseases, growing geriatric population globally, need for cost-containment and improved patient care in healthcare industry, and wearables, health apps and connected devices enhancing remote patient monitoring solutions) restraints (high investments and lack of it expertise, behavioral barriers and healthcare affordability challenges in remote patient monitoring, and regulatory barriers in 2024 medicare policies impacting remote patient monitoring) opportunities (emergence of AI & ML, growing shift toward outpatient care environments, growing use in combating infectious diseases and enhanced patient care through early detection, hospital-at-home, and enhanced patient care through early detection and continuous monitoring) challenges (growing data security concerns data security issues, data accessibility issues, and integration of social determinants of health (sdoh) factors into rpm programs) influencing the growth of the remote patient monitoring market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the remote patient monitoring market
• Market Development: Comprehensive information about lucrative markets – the report analyses the remote patient monitoring market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the remote patient monitoring market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players such as Koninklijke Philips N.V. (Netherlands), Medtronic (Ireland), OMRON Corporation (Japan), GE Healthcare (US), Boston Scientific Corporation (US), Abbott (US), NIHON KOHDEN CORPORATION (Japan), and Siemens Healthineers AG); among others in the remote patient monitoring market

Table of Contents

1               INTRODUCTION              33

1.1           STUDY OBJECTIVES       33

1.2           MARKET DEFINITION   33

1.3           MARKET SCOPE                34

1.3.1        MARKET SEGMENTATION           34

1.3.2        INCLUSIONS & EXCLUSIONS       35

1.3.3        YEARS CONSIDERED      36

1.3.4        CURRENCY CONSIDERED            36

1.4           LIMITATIONS    37

1.5           STAKEHOLDERS               37

1.6           SUMMARY OF CHANGES               38

2               RESEARCH METHODOLOGY       40

2.1           RESEARCH DATA              40

2.1.1        SECONDARY DATA          41

2.1.1.1    Key data from secondary sources       41

2.1.2        PRIMARY DATA 42

2.1.2.1    Key data from primary sources           43

2.1.2.2    Breakdown of primary sources           44

2.2           MARKET SIZE ESTIMATION         45

2.2.1        SUPPLY-SIDE ANALYSIS                 46

2.2.2        BOTTOM-UP APPROACH: END-USER ADOPTION                 48

2.2.3        TOP-DOWN OF PARENT MARKET ASSESSMENT 49

2.2.4        COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS      49

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 53

2.4           RESEARCH ASSUMPTIONS           54

2.4.1        MARKET SIZING ASSUMPTIONS                54

2.4.2        OVERALL STUDY ASSUMPTIONS              54

2.5           RISK ASSESSMENT           55

2.6           RESEARCH LIMITATIONS             55

2.6.1        METHODOLOGY-RELATED LIMITATIONS           55

2.6.2        SCOPE-RELATED LIMITATIONS                 55

3               EXECUTIVE SUMMARY  56

4               PREMIUM INSIGHTS       60

4.1           REMOTE PATIENT MONITORING MARKET OVERVIEW                 60

4.2           NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER

AND REGION (2023)         61

4.3           GEOGRAPHIC GROWTH OPPORTUNITIES            62

4.4           REMOTE PATIENT MONITORING MARKET: DEVELOPED MARKETS VS.

EMERGING MARKETS  62

5               MARKET OVERVIEW       63

5.1           INTRODUCTION              63

5.1.1        DRIVERS               65

5.1.1.1    Transformation of patient care through digital innovation                 65

5.1.1.2    Expansion of telehealth in remote patient monitoring   67

5.1.1.3    Rising prevalence of chronic diseases                67

5.1.1.4    Increasing geriatric population and rising uptake of RPM services                 68

5.1.1.5    Growing need for cost-containment across healthcare facilities                 69

5.1.1.6    Technological innovation in wearables, mhealth apps, and connected devices 70

5.1.2        RESTRAINTS      71

5.1.2.1    High investments and lack of IT expertise       71

5.1.2.2    Behavioral barriers and healthcare affordability challenges in remote patient monitoring  71

5.1.2.3    Challenges associated with 2024 CMS regulations         71

5.1.3        OPPORTUNITIES              72

5.1.3.1    Emergence of AI & ML       72

5.1.3.2    Gradual shift toward outpatient care environments        73

5.1.3.3    Increasing utilization for infectious disease diagnostics 74

5.1.3.4    Rising initiatives for hospital-at-home programs             74

5.1.4        CHALLENGES    75

5.1.4.1    Concerns associated with data security             75

5.1.4.2    Data accessibility issues      77

5.1.4.3    incorporation of SDOH factors into RPM programs      78

5.2           TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       78

5.2.1        REVENUE SHIFTS AND NEW REVENUE POCKETS FOR REMOTE PATIENT MONITORING MARKET          78

5.3           INDUSTRY TRENDS         79

5.3.1        GRADUAL SHIFT TO VALUE-BASED & PATIENT-CENTRIC CARE 79

5.4           ECOSYSTEM ANALYSIS  79

5.5           VALUE CHAIN ANALYSIS               81

5.6           TECHNOLOGY ANALYSIS             82

5.6.1        KEY TECHNOLOGIES     82

5.6.1.1    Miniature wearable devices 82

5.6.1.2    Artificial intelligence & machine learning        83

5.6.1.3    Cloud computing  83

5.6.1.4    Patient engagement tools   83

5.6.1.5    EHR integration   83

5.6.1.6    Voice assistant integration  84

5.6.2        COMPLEMENTARY TECHNOLOGIES       84

5.6.2.1    5G connectivity     84

5.6.2.2    mHealth apps        84

5.6.2.3    Digital therapeutics              84

5.6.2.4    Telehealth platforms            85

5.6.3        ADJACENT TECHNOLOGIES       85

5.6.3.1    POC diagnostics   85

5.6.3.2    Smart home health devices 85

5.7           TARIFF & REGULATORY ANALYSIS           86

5.7.1        TARIFF DATA (HS CODE 9018)    86

5.7.2        TARIFF DATA (HS CODE 9021)    87

5.7.3        TARIFF DATA (HS CODE 9022)    88

5.7.4        REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS             89

5.7.5        REGULATORY ANALYSIS               93

5.8           TRADE ANALYSIS             97

5.8.1        TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES

(HSN CODE: 90189099)    97

5.8.2        TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES

(HSN CODE: 9021)             98

5.8.3        TRADE ANALYSIS FOR REMOTE PATIENT MONITORING DEVICES

(HSN CODE: 9022)             99

5.9           PRICING ANALYSIS          100

5.9.1        INDICATIVE PRICING FOR REMOTE PATIENT MONITORING DEVICES,

BY KEY PLAYER (2023)    101

5.9.2        INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES (2023)    102

5.10         PORTER’S FIVE FORCES ANALYSIS           102

5.10.1      THREAT OF NEW ENTRANTS      104

5.10.2      THREAT OF SUBSTITUTES          104

5.10.3      BARGAINING POWER OF MANUFACTURERS       104

5.10.4      BARGAINING POWER OF BUYERS             104

5.10.5      INTENSITY OF COMPETITIVE RIVALRY 105

5.11         PATENT ANALYSIS          105

5.11.1      PATENT PUBLICATION TRENDS FOR REMOTE PATIENT MONITORING   105

5.11.2      JURISDICTION AND TOP APPLICANT COUNTRIES FOR

REMOTE PATIENT MONITORING             106

5.11.3      LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET               108

5.12         KEY STAKEHOLDERS AND BUYING CRITERIA     109

5.12.1      KEY STAKEHOLDERS IN BUYING PROCESS           109

5.12.2      BUYING CRITERIA           110

5.13         END-USER ANALYSIS      110

5.13.1      UNMET NEEDS 110

5.13.2      END-USER EXPECTATIONS         111

5.14         KEY CONFERENCES AND EVENTS, 2025−2026      112

5.14.1      REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2025−2026    112

5.15         CASE STUDY ANALYSIS 113

5.15.1      REMOTE PATIENT MONITORING PORTAL AUTOMATION  113

5.15.1.1  Case 1: Cost savings and performance boost through automation                 113

5.15.2      PATIENT MONITORING PORTAL AUTOMATION                 114

5.15.2.1  Case 2: RPM drives engagement and generates substantial returns    114

5.16         INVESTMENT AND FUNDING SCENARIO               115

5.17         REMOTE PATIENT MONITORING BUSINESS MODEL                 115

5.17.1      SUBSCRIPTION-BASED MODELS               115

5.17.2      PLATFORM AS A SERVICE (PAAS)              115

5.17.3      FREEMIUM MODELS WITH PREMIUM FEATURES                 115

5.17.4      COLLABORATIVE ECOSYSTEMS & PARTNERSHIPS                 116

5.18         IMPACT OF GENERATIVE AI/AI ON REMOTE PATIENT MONITORING MARKET 116

5.18.1      KEY USE CASES 117

5.18.2      CASE STUDIES FOR GENERATIVE AI/AI IMPLEMENTATION         118

5.18.2.1  Case study 1: Enhancing remote patient monitoring for cancer treatment with NLP and HIPAA-compliant annotation                 118

5.18.2.2  Case study 2: Leveraging AI for proactive infection prevention in hospitals 119

5.18.3      IMPACT OF AI/GEN AI ON INTERCONNECTED & ADJACENT ECOSYSTEMS              120

5.18.3.1  Telehealth & telemedicine  120

5.18.3.2  Wearable devices  120

5.18.3.3  Digital healthcare 121

5.18.3.4  Home healthcare  121

5.18.4      USER READINESS & IMPACT ASSESSMENT            121

5.18.4.1  User readiness       121

5.18.4.1.1                User A: Hospitals 121

5.18.4.1.2                User B: Ambulatory surgery centers 121

5.18.4.2  Impact assessment                122

5.18.4.2.1                User A: Hospitals 122

5.18.4.2.1.1            Implementation    122

5.18.4.2.1.2            Impact    122

5.18.4.2.2                User B: Ambulatory surgery centers 122

5.18.4.2.2.1            Implementation    122

5.18.4.2.2.2            Impact    123

5.19         REIMBURSEMENT SCENARIO     123

6               REMOTE PATIENT MONITORING MARKET, BY COMPONENT    126

6.1           INTRODUCTION              127

6.2           DEVICES              127

6.2.1        BY FUNCTION   128

6.2.1.1    Cardiac monitoring devices                 129

6.2.1.1.1 Increasing uptake of ECG monitors and rising cases of hypertension to fuel market                129

6.2.1.2    Neurological monitoring devices       130

6.2.1.2.1 Growing demand for clinical-grade wearable devices for routine monitoring to drive market 130

6.2.1.3    Respiratory monitoring devices          131

6.2.1.3.1 Rising demand for peak flow meters and sleep apnea monitors to fuel market             131

6.2.1.4    Blood glucose monitoring devices     132

6.2.1.4.1 Increasing prevalence of diabetes to support market growth                 132

6.2.1.5    Fetal & neonatal monitoring devices 133

6.2.1.5.1 Growing focus on vital health monitoring in preterm births to drive market          133

6.2.1.6    Weight monitoring devices 134

6.2.1.6.1 High incidence of obesity and growing advancements in smart weighing scales to fuel market            134

6.2.1.7    Multiparameter monitoring devices  135

6.2.1.7.1 Measurement of spO2, blood sugar, and respiratory activity to fuel uptake             135

6.2.1.8    Pulse oximeter devices         136

6.2.1.8.1 Rising demand in preoperative & home care settings to support market growth       136

6.2.1.9    Thermometers      137

6.2.1.9.1 Growing focus on home healthcare to fuel market          137

6.2.1.10  Other monitoring devices   138

6.2.2        BY TYPE               139

6.2.2.1    Wearable devices  140

6.2.2.1.1 Ability to provide real-time insights to drive market      140

6.2.2.2    Implantable devices              141

6.2.2.2.1 Advancements in wireless communication technologies to boost demand  141

6.2.2.3    Handheld & portable devices              142

6.2.2.3.1 Growing focus on device miniaturization to fuel market                 142

6.2.2.4    Other devices        143

6.3           SOFTWARE         143

6.3.1        SOFTWARE, BY DEPLOYMENT MODEL  144

6.3.1.1    On-premise models              145

6.3.1.1.1 Enhanced control, data security, and customization benefits to fuel market             145

6.3.1.2    Cloud-based models             145

6.3.1.2.1 Real-time data sharing and high-security features to boost demand  145

6.3.2        SOFTWARE, BY TRANSMISSION TYPE     146

6.3.2.1    Synchronous transmission  147

6.3.2.1.1 Growing availability of real-time data analytics to boost demand                 147

6.3.2.2    Asynchronous transmission                 148

6.3.2.2.1 Increasing need for low-resource flexible solutions to support market growth       148

6.4           SERVICES             148

6.4.1        EXPANSION OF TELEMEDICINE PLATFORMS AND INTEGRATION OF SERVICE MODELS TO SUPPORT MARKET GROWTH             148

7               REMOTE PATIENT MONITORING MARKET, BY INDICATION      150

7.1           INTRODUCTION              151

7.2           ONCOLOGY        151

7.2.1        GROWING FOCUS ON EARLY DISEASE DETECTION TO DRIVE MARKET 151

7.3           CARDIOLOGY    153

7.3.1        HIGH INCIDENCE OF CVD TO PROPEL MARKET                 153

7.4           NEUROLOGY     154

7.4.1        INCREASING PREVALENCE OF NEUROLOGICAL CONDITIONS

TO FUEL MARKET            154

7.5           DIABETES           155

7.5.1        GROWING FOCUS ON TELEHEALTH CONSULTATIONS FOR DIABETES MANAGEMENT TO BOOST DEMAND      155

7.6           SLEEP DISORDERS           156

7.6.1        INCREASING INCIDENCE OF SLEEP APNEA TO SUPPORT MARKET GROWTH          156

7.7           RESPIRATORY DISEASES               157

7.7.1        RISING CASES OF COPD AND ASTHMA TO FUEL MARKET               157

7.8           WELLNESS IMPROVEMENT         158

7.8.1        UTILIZATION OF WEIGHT MANAGEMENT & PERSONAL HEALTH

APPS TO SUPPORT MARKET GROWTH  158

7.9           MENTAL HEALTH            159

7.9.1        GROWING FOCUS ON DEVELOPMENT OF PREDICTIVE HEALTH MODELS

FOR COGNITIVE THERAPY TO PROPEL MARKET               159

7.10         OTHER INDICATIONS   160

8               REMOTE PATIENT MONITORING MARKET, BY END USER     162

8.1           INTRODUCTION              163

8.2           HEALTHCARE PROVIDERS           163

8.2.1        HOSPITALS         165

8.2.1.1    Ability to purchase technologically advanced telehealth devices to fuel market             165

8.2.2        ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS                 166

8.2.2.1    Increasing demand for cost-effective perioperative devices

to fuel market        166

8.2.3        LONG-TERM CARE & ASSISTED LIVING FACILITIES                 166

8.2.3.1    Expanding geriatric population and growing focus on chronic disease management to fuel market  166

8.2.4        HOME HEALTHCARE      167

8.2.4.1    Growing preference for remote care to drive market      167

8.2.5        OTHER HEALTHCARE PROVIDERS           168

8.3           HEALTHCARE PAYERS   169

8.3.1        LOW COSTS AND IMPROVED HEALTHCARE FACILITIES TO DRIVE MARKET         169

8.4           PATIENTS            170

8.4.1        INCREASING FOCUS ON AI INTEGRATION INTO WEARABLE DEVICES

TO BOOST DEMAND      170

8.5           PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES                 171

8.5.1        RISING NEED FOR ENHANCED CLINICAL TRIAL OUTCOMES

TO SUPPORT MARKET GROWTH              171

8.6           MEDTECH COMPANIES 172

8.6.1        INTEGRATION OF RPM WITH MEDTECH SOLUTIONS FOR

DIAGNOSTIC ACCURACY TO FUEL MARKET       172

8.7           OTHER END USERS         173

9               REMOTE PATIENT MONITORING MARKET, BY REGION                 174

9.1           INTRODUCTION              175

9.2           NORTH AMERICA             175

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 177

9.2.2        US           181

9.2.2.1    Supportive regulatory frameworks for AI implementation in wearable devices to boost demand     181

9.2.3        CANADA               186

9.2.3.1    Growing need to curtail healthcare costs to drive market                 186

9.3           EUROPE               190

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      190

9.3.2        GERMANY           194

9.3.2.1    Favorable reimbursements for technological innovation to propel market    194

9.3.3        UK          198

9.3.3.1    Government support for AI implementation to boost demand                 198

9.3.4        FRANCE                202

9.3.4.1    Implementation of ETAPES program to fuel market     202

9.3.5        ITALY    206

9.3.5.1    Growing focus on digital transformation for value-centric patient care to drive market              206

9.3.6        SPAIN    210

9.3.6.1    Rising funding investments for digital health plans to boost market    210

9.3.7        REST OF EUROPE             214

9.4           ASIA PACIFIC     218

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 218

9.4.2        CHINA  224

9.4.2.1    Shortage of physicians and growing focus on RPM solutions to support market growth        224

9.4.3        JAPAN   228

9.4.3.1    Rising geriatric population and subsequent rise in preventive care to drive market      228

9.4.4        INDIA    232

9.4.4.1    Expanding target patient population to drive market     232

9.4.5        REST OF ASIA PACIFIC   235

9.5           LATIN AMERICA                239

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 240

9.5.2        BRAZIL 244

9.5.2.1    Growing focus on telehealth consultations to drive market                 244

9.5.3        MEXICO                248

9.5.3.1    Improvements in healthcare infrastructure to boost demand                 248

9.5.4        REST OF LATIN AMERICA             252

9.6           MIDDLE EAST & AFRICA                256

9.7           MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 256

9.7.1        GCC COUNTRIES              261

9.7.1.1    Government initiatives for investments in RPM solutions

to support market growth    261

9.7.2        REST OF MIDDLE EAST & AFRICA             264

10            COMPETITIVE LANDSCAPE         269

10.1         OVERVIEW          269

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            269

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET    269

10.3         REVENUE ANALYSIS, 2019–2023  274

10.4         MARKET SHARE ANALYSIS, 2023                 275

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 278

10.5.1      STARS   279

10.5.2      EMERGING LEADERS     279

10.5.3      PERVASIVE PLAYERS      279

10.5.4      PARTICIPANTS 279

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         281

10.5.5.1  Company footprint               281

10.5.5.2  Region footprint   282

10.5.5.3  Component footprint           283

10.5.5.4  Indication footprint              284

10.5.5.5  End-user footprint                285

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        286

10.6.1      PROGRESSIVE COMPANIES         286

10.6.2      RESPONSIVE COMPANIES            286

10.6.3      DYNAMIC COMPANIES  286

10.6.4      STARTING BLOCKS         286

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 288

10.6.5.1  Detailed list of key startups/SMEs    288

10.6.5.2  Competitive benchmarking of startups/SMEs 288

10.7         COMPANY VALUATION & FINANCIAL METRICS 289

10.7.1      FINANCIAL METRICS      289

10.7.2      COMPANY VALUATION 289

10.8         BRAND/SOFTWARE COMPARISON           290

10.9         COMPETITIVE SCENARIO             291

10.9.1      PRODUCT/SERVICE LAUNCHES & APPROVALS  291

10.9.2      DEALS  293

10.9.3      EXPANSIONS     296

10.9.4      OTHER DEVELOPMENTS              296

11            COMPANY PROFILES      297

11.1         KEY PLAYERS     297

11.1.1      KONINKLIJKE PHILIPS N.V.          297

11.1.1.1  Business overview 297

11.1.1.2  Products/Services offered   298

11.1.1.3  Recent developments           302

11.1.1.3.1                Product/Service launches & approvals              302

11.1.1.3.2                Deals      303

11.1.1.4  MnM view              304

11.1.1.4.1                Key strengths        304

11.1.1.4.2                Strategic choices   304

11.1.1.4.3                Weaknesses & competitive threats     304

11.1.2      OMRON HEALTHCARE, INC. (SUBSIDIARY OF OMRON CORPORATION)               305

11.1.2.1  Business overview 305

11.1.2.2  Products/Services offered   306

11.1.2.3  Recent developments           308

11.1.2.3.1                Product/Service launches   308

11.1.2.3.2                Deals      309

11.1.2.3.3                Other developments             309

11.1.2.4  MnM view              310

11.1.2.4.1                Key strengths        310

11.1.2.4.2                Strategic choices   310

11.1.2.4.3                Weaknesses & competitive threats     310

11.1.3      MEDTRONIC      311

11.1.3.1  Business overview 311

11.1.3.2  Products/Services offered   312

11.1.3.3  Recent developments           314

11.1.3.3.1                Product/Service approvals  314

11.1.3.3.2                Deals      315

11.1.3.4  MnM view              316

11.1.3.4.1                Key strengths        316

11.1.3.4.2                Strategic choices   316

11.1.3.4.3                Weaknesses & competitive threats     316

11.1.4      GE HEALTHCARE             317

11.1.4.1  Business overview 317

11.1.4.2  Products/Services offered   318

11.1.4.3  Recent developments           320

11.1.4.3.1                Product/Service launches & approvals              320

11.1.4.3.2                Deals      321

11.1.4.4  MnM view              322

11.1.4.4.1                Key strengths        322

11.1.4.4.2                Strategic choices   322

11.1.4.4.3                Weaknesses & competitive threats     322

11.1.5      ABBOTT               323

11.1.5.1  Business overview 323

11.1.5.2  Products/Services offered   324

11.1.5.3  Recent developments           325

11.1.5.3.1                Product/Service launches   325

11.1.5.3.2                Deals      326

11.1.5.3.3                Expansions             327

11.1.5.4  MnM view              327

11.1.5.4.1                Key strengths        327

11.1.5.4.2                Strategic choices   327

11.1.5.4.3                Weaknesses & competitive threats     327

11.1.6      ORACLE                328

11.1.6.1  Business overview 328

11.1.6.2  Products/Services offered   329

11.1.6.3  Recent developments           330

11.1.6.3.1                Deals      330

11.1.7      BOSTON SCIENTIFIC CORPORATION     331

11.1.7.1  Business overview 331

11.1.7.2  Products/Services offered   332

11.1.7.3  Recent developments           333

11.1.7.3.1                Product/Service launches & enhancements     333

11.1.7.3.2                Deals      334

11.1.7.3.3                Expansions             334

11.1.8      NIHON KOHDEN CORPORATION              335

11.1.8.1  Business overview 335

11.1.8.2  Products/Services offered   337

11.1.8.3  Recent developments           338

11.1.8.3.1                Product/Service launches   338

11.1.8.3.2                Deals      338

11.1.8.3.3                Expansions             339

11.1.9      SIEMENS HEALTHINEERS AG      340

11.1.9.1  Business overview 340

11.1.9.2  Products/Services offered   341

11.1.9.3  Recent developments           342

11.1.9.3.1                Product/Service launches & approvals              342

11.1.9.3.2                Deals      343

11.1.10   BAXTER                344

11.1.10.1                 Business overview 344

11.1.10.2                 Products/Services offered   346

11.1.10.3                 Recent developments           346

11.1.10.3.1             Product/Service launches & approvals              346

11.1.10.3.2             Deals      347

11.1.11   BIOBEAT              348

11.1.11.1                 Business overview 348

11.1.11.2                 Products/Services offered   348

11.1.11.3                 Recent developments           349

11.1.11.3.1             Product/Service launches & approvals              349

11.1.11.3.2             Deals      350

11.1.12   BIOTRONIK        352

11.1.12.1                 Business overview 352

11.1.12.2                 Products/Services offered   352

11.1.12.3                 Recent developments           353

11.1.12.3.1             Product/Service launches & approvals              353

11.1.12.3.2             Deals      354

11.1.13   VITALCONNECT               355

11.1.13.1                 Business overview 355

11.1.13.2                 Products/Services offered   355

11.1.13.3                 Recent developments           356

11.1.13.3.1             Product/Service launches   356

11.1.13.3.2             Deals      356

11.1.13.3.3             Other developments             357

11.1.14   VIVALNK, INC.   358

11.1.14.1                 Business overview 358

11.1.14.2                 Products/Services offered   358

11.1.14.3                 Recent developments           359

11.1.14.3.1             Product/Service launches & enhancements     359

11.1.14.3.2             Deals      360

11.1.15   CLEARARCH, INC.            361

11.1.15.1                 Business overview 361

11.1.15.2                 Products/Services offered   361

11.1.15.3                 Recent developments           362

11.1.15.3.1             Product/Service launches   362

11.1.15.3.2             Deals      363

11.1.16   OPTUM, INC. (VIVIFY HEALTH, PART OF OPTUM)                 364

11.1.16.1                 Business overview 364

11.1.16.2                 Products/Services offered   365

11.1.17   BLUE SPARK TECHNOLOGIES, INC.         366

11.1.17.1                 Business overview 366

11.1.17.2                 Products/Services offered   366

11.1.17.3                 Recent developments           367

11.1.17.3.1             Product/Service launches   367

11.1.17.3.2             Deals      367

11.1.17.3.3             Other developments             368

11.1.18   LIGHTBEAM       369

11.1.18.1                 Business overview 369

11.1.18.2                 Products/Services offered   369

11.1.18.3                 Recent developments           370

11.1.18.3.1             Deals      370

11.1.19   CLOUD DIAGNOSTICS CANADA ULC      371

11.1.19.1                 Business overview 371

11.1.19.2                 Products/Services offered   371

11.1.19.3                 Recent developments           372

11.1.19.3.1             Product/Service launches   372

11.1.19.3.2             Deals      372

11.1.20   TELADOC HEALTH, INC.               374

11.1.20.1                 Business overview 374

11.1.20.2                 Products/Services offered   375

11.1.20.3                 Recent developments           376

11.1.20.3.1             Product/Service launches   376

11.1.20.3.2             Deals      377

11.1.21   GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.      378

11.1.21.1                 Business overview 378

11.1.21.2                 Products/Services offered   379

11.1.21.3                 Recent developments           380

11.1.21.3.1             Product/Service launches   380

11.2         OTHER PLAYERS              381

11.2.1      CARESIMPLE INC.            381

11.2.2      TIMEDOC, INC. 382

11.2.3      MD REVOLUTION INC.  383

11.2.4      OPTIMIZE HEALTH, INC.              384

11.2.5      HEALTH RECOVERY SOLUTIONS              385

12            APPENDIX           386

12.1         DISCUSSION GUIDE        386

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                391

12.3         CUSTOMIZATION OPTIONS        393

12.4         RELATED REPORTS         394

12.5         AUTHOR DETAILS           395

LIST OF TABLES

TABLE 1                EXCHANGE RATES UTILIZED FOR CONVERSION TO USD                37

TABLE 2                FACTOR ANALYSIS          50

TABLE 3                RISK ASSESSMENT: REMOTE PATIENT MONITORING MARKET 55

TABLE 4                REMOTE PATIENT MONITORING MARKET: IMPACT ANALYSIS           64

TABLE 5                RECENT DEVELOPMENTS OF AI IN REMOTE PATIENT MONITORING MARKET, JANUARY 2022–DECEMBER 2024        73

TABLE 6                TOP 5 HEALTHCARE ORGANIZATIONS IMPACTED BY SECURITY BREACHES       77

TABLE 7                NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  89

TABLE 8                EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  90

TABLE 9                ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  91

TABLE 10             LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  92

TABLE 11              MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             93

TABLE 12              NORTH AMERICA: REGULATORY ANALYSIS                 93

TABLE 13              EUROPE: REGULATORY ANALYSIS           94

TABLE 14              ASIA PACIFIC: REGULATORY ANALYSIS 95

TABLE 15              MIDDLE EAST & AFRICA: REGULATORY ANALYSIS            96

TABLE 16              LATIN AMERICA: REGULATORY ANALYSIS                 96

TABLE 17              INDICATIVE PRICE FOR REMOTE PATIENT MONITORING DEVICES,

BY KEY PLAYER (2023)    101

TABLE 18              AVERAGE SELLING PRICE FOR REMOTE PATIENT MONITORING DEVICES,

BY KEY DEVICE (2023)    101

TABLE 19              INDICATIVE PRICE OF REMOTE PATIENT MONITORING DEVICES, BY REGION,

2023 (USD)          102

TABLE 20              REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS           103

TABLE 21              JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR

REMOTE PATIENT MONITORING             107

TABLE 22              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR REMOTE PATIENT MONITORING, BY END USERS                 109

TABLE 23              KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING   110

TABLE 24              UNMET NEEDS IN REMOTE PATIENT MONITORING MARKET 111

TABLE 25              END-USER EXPECTATIONS IN REMOTE PATIENT MONITORING MARKET              111

TABLE 26              CPT CODES AND REIMBURSEMENT ANALYSIS OF US RPM MARKET       124

TABLE 27              REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            127

TABLE 28              REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY REGION,

2022–2030 (USD MILLION)            128

TABLE 29              REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,

2022–2030 (USD MILLION)            129

TABLE 30              CARDIAC MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          130

TABLE 31              NEUROLOGICAL MONITORING DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            131

TABLE 32              RESPIRATORY MONITORING DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            132

TABLE 33              BLOOD GLUCOSE MONITORING DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            133

TABLE 34              FETAL & NEONATAL MONITORING DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            134

TABLE 35              WEIGHT MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          135

TABLE 36              MULTIPARAMETER MONITORING DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            136

TABLE 37              PULSE OXIMETER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          137

TABLE 38              THERMOMETERS MARKET, BY REGION, 2022–2030 (USD MILLION)       138

TABLE 39              OTHER MONITORING DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)          138

TABLE 40              REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            139

TABLE 41              REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (THOUSAND UNITS)  139

TABLE 42              WEARABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)            140

TABLE 43              IMPLANTABLE DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)            141

TABLE 44              HANDHELD & PORTABLE DEVICES MARKET, BY REGION,

2022–2030 (USD MILLION)            142

TABLE 45              OTHER DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION)       143

TABLE 46              REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY REGION,

2022–2030 (USD MILLION)            144

TABLE 47              REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT MODEL, 2022–2030 (USD MILLION)            144

TABLE 48              ON-PREMISE MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)            145

TABLE 49              CLOUD-BASED MODELS MARKET, BY REGION, 2022–2030 (USD MILLION)            146

TABLE 50              REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)                 147

TABLE 51              SYNCHRONOUS TRANSMISSION MARKET, BY REGION, 2022–2030 (USD MILLION)          147

TABLE 52              ASYNCHRONOUS TRANSMISSION MARKET, BY REGION,

2022–2030 (USD MILLION)            148

TABLE 53              REMOTE PATIENT MONITORING MARKET FOR SERVICES, BY REGION,

2022–2030 (USD MILLION)            149

TABLE 54              REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            151

TABLE 55              REMOTE PATIENT MONITORING MARKET FOR ONCOLOGY, BY REGION,

2022–2030 (USD MILLION)            152

TABLE 56              REMOTE PATIENT MONITORING MARKET FOR CARDIOLOGY, BY REGION,

2022–2030 (USD MILLION)            153

TABLE 57              REMOTE PATIENT MONITORING MARKET FOR NEUROLOGY, BY REGION,

2022–2030 (USD MILLION)            154

TABLE 58              REMOTE PATIENT MONITORING MARKET FOR DIABETES, BY REGION,

2022–2030 (USD MILLION)            156

TABLE 59              REMOTE PATIENT MONITORING MARKET FOR SLEEP DISORDERS,

BY REGION, 2022–2030 (USD MILLION)   157

TABLE 60              REMOTE PATIENT MONITORING MARKET FOR RESPIRATORY DISEASES,

BY REGION, 2022–2030 (USD MILLION)   158

TABLE 61              REMOTE PATIENT MONITORING MARKET FOR WELLNESS IMPROVEMENT,

BY REGION, 2022–2030 (USD MILLION)   159

TABLE 62              REMOTE PATIENT MONITORING MARKET FOR MENTAL HEALTH, BY REGION, 2022–2030 (USD MILLION)                 160

TABLE 63              REMOTE PATIENT MONITORING MARKET FOR OTHER INDICATIONS, BY REGION, 2022–2030 (USD MILLION)                 161

TABLE 64              REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            163

TABLE 65              REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)       164

TABLE 66              REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY REGION, 2022–2030 (USD MILLION)   164

TABLE 67              REMOTE PATIENT MONITORING MARKET FOR HOSPITALS, BY REGION,

2022–2030 (USD MILLION)            165

TABLE 68              REMOTE PATIENT MONITORING MARKET FOR ASCS, ACCS, AND OTHER OUTPATIENT SETTINGS, BY REGION, 2022–2030 (USD MILLION)            166

TABLE 69              REMOTE PATIENT MONITORING MARKET FOR LONG-TERM CARE & ASSISTED LIVING FACILITIES, BY REGION, 2022–2030 (USD MILLION)            167

TABLE 70              REMOTE PATIENT MONITORING MARKET FOR HOME HEALTHCARE, BY REGION, 2022–2030 (USD MILLION)                 168

TABLE 71              REMOTE PATIENT MONITORING MARKET FOR OTHER HEALTHCARE PROVIDERS,

BY REGION, 2022–2030 (USD MILLION)   169

TABLE 72              REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PAYERS,

BY REGION, 2022–2030 (USD MILLION)   170

TABLE 73              REMOTE PATIENT MONITORING MARKET FOR PATIENTS, BY REGION,

2022–2030 (USD MILLION)            171

TABLE 74              REMOTE PATIENT MONITORING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2030 (USD MILLION)          172

TABLE 75              REMOTE PATIENT MONITORING MARKET FOR MEDTECH COMPANIES, BY REGION, 2022–2030 (USD MILLION)                 173

TABLE 76              REMOTE PATIENT MONITORING MARKET FOR OTHER END USERS, BY REGION, 2022–2030 (USD MILLION)                 173

TABLE 77              REMOTE PATIENT MONITORING MARKET, BY REGION, 2022–2030 (USD MILLION)          175

TABLE 78              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            177

TABLE 79              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            177

TABLE 80              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             178

TABLE 81              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         179

TABLE 82              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        179

TABLE 83              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          179

TABLE 84              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            180

TABLE 85              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            180

TABLE 86              NORTH AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                181

TABLE 87              US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,

2022–2030 (USD MILLION)            183

TABLE 88              US: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            183

TABLE 89              US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)            184

TABLE 90              US: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)            184

TABLE 91              US: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            184

TABLE 92              US: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            185

TABLE 93              US: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         185

TABLE 94              CANADA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            186

TABLE 95              CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            187

TABLE 96              CANADA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            187

TABLE 97              CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        188

TABLE 98              CANADA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          188

TABLE 99              CANADA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            188

TABLE 100            CANADA: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            189

TABLE 101            CANADA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 189

TABLE 102            EUROPE: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            190

TABLE 103            EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            191

TABLE 104            EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            191

TABLE 105            EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            192

TABLE 106            EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        192

TABLE 107            EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          192

TABLE 108            EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            193

TABLE 109            EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            193

TABLE 110            EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 194

TABLE 111            GERMANY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            195

TABLE 112            GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            195

TABLE 113            GERMANY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)                 196

TABLE 114            GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        196

TABLE 115            GERMANY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          196

TABLE 116            GERMANY: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            197

TABLE 117            GERMANY: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            197

TABLE 118            GERMANY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 198

TABLE 119            UK: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            199

TABLE 120            UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION,

2022–2030 (USD MILLION)            199

TABLE 121            UK: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            200

TABLE 122            UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)            200

TABLE 123            UK: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)            200

TABLE 124            UK: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            201

TABLE 125            UK: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            201

TABLE 126            UK: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         202

TABLE 127            FRANCE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            203

TABLE 128            FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            203

TABLE 129            FRANCE: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            204

TABLE 130            FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        204

TABLE 131            FRANCE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          204

TABLE 132            FRANCE: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            205

TABLE 133            FRANCE: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            205

TABLE 134            FRANCE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 206

TABLE 135            ITALY: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            207

TABLE 136            ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            207

TABLE 137            ITALY: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            208

TABLE 138            ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        208

TABLE 139            ITALY: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          208

TABLE 140            ITALY: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            209

TABLE 141            ITALY: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            209

TABLE 142            ITALY: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         210

TABLE 143            SPAIN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            211

TABLE 144            SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            211

TABLE 145            SPAIN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            212

TABLE 146            SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        212

TABLE 147            SPAIN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          212

TABLE 148            SPAIN: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            213

TABLE 149            SPAIN: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            213

TABLE 150            SPAIN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         214

TABLE 151            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            215

TABLE 152            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             215

TABLE 153            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         216

TABLE 154            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        216

TABLE 155            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          216

TABLE 156            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)            217

TABLE 157            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            217

TABLE 158            REST OF EUROPE: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                218

TABLE 159            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            220

TABLE 160            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            220

TABLE 161            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             221

TABLE 162            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         221

TABLE 163            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        222

TABLE 164            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          222

TABLE 165            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            222

TABLE 166            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            223

TABLE 167            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 223

TABLE 168            CHINA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            224

TABLE 169            CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            225

TABLE 170            CHINA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            225

TABLE 171            CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        226

TABLE 172            CHINA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION) 226

TABLE 173            CHINA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            226

TABLE 174            CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            227

TABLE 175            CHINA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         227

TABLE 176            JAPAN: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            228

TABLE 177            JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            229

TABLE 178            JAPAN: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            229

TABLE 179            JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        230

TABLE 180            JAPAN: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION) 230

TABLE 181            JAPAN: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            230

TABLE 182            JAPAN: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            231

TABLE 183            JAPAN: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         231

TABLE 184            INDIA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            232

TABLE 185            INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            233

TABLE 186            INDIA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            233

TABLE 187            INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        234

TABLE 188            INDIA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION) 234

TABLE 189            INDIA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            234

TABLE 190            INDIA: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            235

TABLE 191            INDIA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS,

BY TYPE, 2022–2030 (USD MILLION)         235

TABLE 192            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            236

TABLE 193            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             237

TABLE 194            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         237

TABLE 195            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)                238

TABLE 196            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)                238

TABLE 197            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)            238

TABLE 198            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET, BY END USER, 2022–2030 (USD MILLION)            239

TABLE 199            REST OF ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                239

TABLE 200            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COUNTRY,

2022–2030 (USD MILLION)            240

TABLE 201            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            241

TABLE 202            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             241

TABLE 203            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)            242

TABLE 204            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        242

TABLE 205            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          242

TABLE 206            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            243

TABLE 207            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            243

TABLE 208            LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                244

TABLE 209            BRAZIL: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            245

TABLE 210            BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            245

TABLE 211            BRAZIL: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            246

TABLE 212            BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        246

TABLE 213            BRAZIL: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          246

TABLE 214            BRAZIL: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            247

TABLE 215            BRAZIL: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            247

TABLE 216            BRAZIL: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 248

TABLE 217            MEXICO: REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2022–2030 (USD MILLION)            249

TABLE 218            MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            249

TABLE 219            MEXICO: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE,

2022–2030 (USD MILLION)            250

TABLE 220            MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        250

TABLE 221            MEXICO: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          250

TABLE 222            MEXICO: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            251

TABLE 223            MEXICO: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            251

TABLE 224            MEXICO: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION) 252

TABLE 225            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET,

BY COMPONENT, 2022–2030 (USD MILLION)        253

TABLE 226            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION) 253

TABLE 227            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)            254

TABLE 228            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)                254

TABLE 229            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)                254

TABLE 230            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET,

BY INDICATION, 2022–2030 (USD MILLION)          255

TABLE 231            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET,

BY END USER, 2022–2030 (USD MILLION)               255

TABLE 232            REST OF LATIN AMERICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                256

TABLE 233            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY REGION, 2022–2030 (USD MILLION)   257

TABLE 234            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY COMPONENT, 2022–2030 (USD MILLION)        257

TABLE 235            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION) 258

TABLE 236            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)            258

TABLE 237            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)                259

TABLE 238            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)                259

TABLE 239            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET, BY INDICATION, 2022–2030 (USD MILLION)            259

TABLE 240            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY END USER, 2022–2030 (USD MILLION)               260

TABLE 241            MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                260

TABLE 242            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY COMPONENT, 2022–2030 (USD MILLION)            261

TABLE 243            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY FUNCTION, 2022–2030 (USD MILLION)             262

TABLE 244            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR DEVICES,

BY TYPE, 2022–2030 (USD MILLION)         262

TABLE 245            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)        263

TABLE 246            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE,

BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION)          263

TABLE 247            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2022–2030 (USD MILLION)            263

TABLE 248            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET, BY END USER,

2022–2030 (USD MILLION)            264

TABLE 249            GCC COUNTRIES: REMOTE PATIENT MONITORING MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)                264

TABLE 250            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY COMPONENT, 2022–2030 (USD MILLION)        265

TABLE 251            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY FUNCTION, 2022–2030 (USD MILLION)            266

TABLE 252            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR DEVICES, BY TYPE, 2022–2030 (USD MILLION)       266

TABLE 253            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY TRANSMISSION TYPE, 2022–2030 (USD MILLION)               267

TABLE 254            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET FOR SOFTWARE, BY DEPLOYMENT TYPE, 2022–2030 (USD MILLION) 267

TABLE 255            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY INDICATION, 2022–2030 (USD MILLION)          267

TABLE 256            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET,

BY END USER, 2022–2030 (USD MILLION)               268

TABLE 257            REST OF MIDDLE EAST & AFRICA: REMOTE PATIENT MONITORING MARKET

FOR HEALTHCARE PROVIDERS, BY TYPE, 2022–2030 (USD MILLION)            268

TABLE 258            OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, JANUARY 2021–JANUARY 2025     269

TABLE 259            REMOTE PATIENT MONITORING MARKET: DEGREE OF COMPETITION         276

TABLE 260            REMOTE PATIENT MONITORING MARKET: REGION FOOTPRINT     282

TABLE 261            REMOTE PATIENT MONITORING MARKET: COMPONENT FOOTPRINT          283

TABLE 262            REMOTE PATIENT MONITORING MARKET: INDICATION FOOTPRINT            284

TABLE 263            REMOTE PATIENT MONITORING MARKET: END-USER FOOTPRINT 285

TABLE 264            REMOTE PATIENT MONITORING MARKET: DETAILED LIST OF KEY

STARTUP/SME PLAYERS               288

TABLE 265            REMOTE PATIENT MONITORING MARKET: COMPETITIVE BENCHMARKING

OF KEY EMERGING PLAYERS/STARTUPS, BY REGION     288

TABLE 266            REMOTE PATIENT MONITORING MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021–JANUARY 2025    291

TABLE 267            REMOTE PATIENT MONITORING MARKET: DEALS, JANUARY 2021–JANUARY 2025      293

TABLE 268            REMOTE PATIENT MONITORING MARKET: EXPANSIONS,

JANUARY 2021–JANUARY 2025     296

TABLE 269            REMOTE PATIENT MONITORING MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025                 296

TABLE 270            KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW          297

TABLE 271            KONINKLIJKE PHILIPS N.V.: PRODUCTS/SERVICES OFFERED               298

TABLE 272            KONINKLIJKE PHILIPS N.V.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025                 302

TABLE 273            KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2021−JANUARY 2025       303

TABLE 274            OMRON CORPORATION: COMPANY OVERVIEW                 305

TABLE 275            OMRON HEALTHCARE, INC.: PRODUCTS/SERVICES OFFERED               306

TABLE 276            OMRON HEALTHCARE, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025                 308

TABLE 277            OMRON HEALTHCARE, INC.: DEALS, JANUARY 2021−JANUARY 2025       309

TABLE 278            OMRON HEALTHCARE, INC.: OTHER DEVELOPMENTS,

JANUARY 2021−JANUARY 2025   309

TABLE 279            MEDTRONIC: COMPANY OVERVIEW       311

TABLE 280            MEDTRONIC: PRODUCTS/SERVICES OFFERED                 312

TABLE 281            MEDTRONIC: PRODUCT/SERVICE APPROVALS, JANUARY 2021−JANUARY 2025   314

TABLE 282            MEDTRONIC: DEALS, JANUARY 2021−JANUARY 2025        315

TABLE 283            GE HEALTHCARE: COMPANY OVERVIEW                 317

TABLE 284            GE HEALTHCARE: PRODUCTS/SERVICES OFFERED             318

TABLE 285            GE HEALTHCARE: PRODUCT/SERVICE LAUNCHES & APPROVALS,

JANUARY 2021−JANUARY 2025 320

TABLE 286            GE HEALTHCARE: DEALS, JANUARY 2021−JANUARY 2025       321

TABLE 287            ABBOTT: COMPANY OVERVIEW                323

TABLE 288            ABBOTT: PRODUCTS/SERVICES OFFERED                 324

TABLE 289            ABBOTT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025   325

TABLE 290            ABBOTT: DEALS, JANUARY 2021−JANUARY 2025                 326

TABLE 291            ABBOTT: EXPANSIONS, JANUARY 2021−JANUARY 2025       327

TABLE 292            ORACLE: COMPANY OVERVIEW                328

TABLE 293            ORACLE: PRODUCTS/SERVICES OFFERED                 329

TABLE 294            ORACLE: DEALS, JANUARY 2021−JANUARY 2025                 330

TABLE 295            BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW   331

TABLE 296            BOSTON SCIENTIFIC CORPORATION: PRODUCTS/SERVICES OFFERED               332

TABLE 297            BOSTON SCIENTIFIC CORPORATION: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021−JANUARY 2025       333

TABLE 298            BOSTON SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−JANUARY 2025   334

TABLE 299            BOSTON SCIENTIFIC CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025       334

TABLE 300            NIHON KOHDEN CORPORATION: COMPANY OVERVIEW          335

TABLE 301            NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED               337

TABLE 302            NIHON KOHDEN CORPORATION: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021−JANUARY 2025   338

TABLE 303            NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021−JANUARY 2025   338

TABLE 304            NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2021−JANUARY 2025   339

TABLE 305            SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW          340

TABLE 306            SIEMENS HEALTHINEERS AG: PRODUCTS/SERVICES OFFERED               341

TABLE 307            SIEMENS HEALTHINEERS AG: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025       342

TABLE 308            SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2021−JANUARY 2025       343

TABLE 309            BAXTER: COMPANY OVERVIEW 344

TABLE 310            BAXTER: PRODUCTS/SERVICES OFFERED                 346

TABLE 311            BAXTER: PRODUCT/SERVICE LAUNCHES & APPROVALS,

JANUARY 2021−JANUARY 2025   346

TABLE 312            BAXTER: DEALS, JANUARY 2021−JANUARY 2025                 347

TABLE 313            BIOBEAT: COMPANY OVERVIEW               348

TABLE 314            BIOBEAT: PRODUCTS/SERVICES OFFERED                 348

TABLE 315            BIOBEAT: PRODUCT/SERVICE LAUNCHES & APPROVALS,

JANUARY 2021−JANUARY 2025   349

TABLE 316            BIOBEAT: DEALS, JANUARY 2021−JANUARY 2025                 350

TABLE 317            BIOTRONIK: COMPANY OVERVIEW         352

TABLE 318            BIOTRONIK: PRODUCTS/SERVICES OFFERED                 352

TABLE 319            BIOTRONIK: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2021−JANUARY 2025        353

TABLE 320            BIOTRONIK: DEALS, JANUARY 2021−JANUARY 2025        354

TABLE 321            VITALCONNECT: COMPANY OVERVIEW                 355

TABLE 322            VITALCONNECT: PRODUCTS/SERVICES OFFERED             355

TABLE 323            VITALCONNECT: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025           356

TABLE 324            VITALCONNECT: DEALS, JANUARY 2021−JANUARY 2025       356

TABLE 325            VITALCONNECT: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025   357

TABLE 326            VIVALNK, INC.: COMPANY OVERVIEW   358

TABLE 327            VIVALNK, INC.: PRODUCTS/SERVICES OFFERED                 358

TABLE 328            VIVALNK, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS,

JANUARY 2021−JANUARY 2025   359

TABLE 329            VIVALNK, INC.: DEALS, JANUARY 2021−JANUARY 2025       360

TABLE 330            CLEARARCH, INC.: COMPANY OVERVIEW                 361

TABLE 331            CLEARARCH, INC.: PRODUCTS/SERVICES OFFERED             361

TABLE 332            CLEARARCH, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025           362

TABLE 333            CLEARARCH, INC.: DEALS, JANUARY 2021−JANUARY 2025       363

TABLE 334            OPTUM, INC.: COMPANY OVERVIEW      364

TABLE 335            OPTUM, INC.: PRODUCTS/SERVICES OFFERED                 365

TABLE 336            BLUE SPARK TECHNOLOGIES, INC.: COMPANY OVERVIEW          366

TABLE 337            BLUE SPARK TECHNOLOGIES, INC.: PRODUCTS/SERVICES OFFERED               366

TABLE 338            BLUE SPARK TECHNOLOGIES, INC.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025                 367

TABLE 339            BLUE SPARK TECHNOLOGIES, INC.: DEALS, JANUARY 2021−JANUARY 2025   367

TABLE 340            BLUE SPARK TECHNOLOGIES, INC.: OTHER DEVELOPMENTS, JANUARY 2021−JANUARY 2025               368

TABLE 341            LIGHTBEAM: COMPANY OVERVIEW        369

TABLE 342            LIGHTBEAM: PRODUCTS/SERVICES OFFERED                 369

TABLE 343            LIGHTBEAM: DEALS, JANUARY 2021−JANUARY 2025        370

TABLE 344            CLOUD DIAGNOSTICS CANADA ULC: COMPANY OVERVIEW          371

TABLE 345            CLOUD DIAGNOSTICS CANADA ULC: PRODUCTS/SERVICES OFFERED               371

TABLE 346            CLOUD DIAGNOSTICS CANADA ULC: PRODUCT LAUNCHES, JANUARY 2021−JANUARY 2025           372

TABLE 347            CLOUD DIAGNOSTICS CANADA ULC: DEALS, JANUARY 2021−JANUARY 2025   372

TABLE 348            TELADOC HEALTH, INC.: COMPANY OVERVIEW                 374

TABLE 349            TELADOC HEALTH, INC.: PRODUCTS/SERVICES OFFERED             375

TABLE 350            TELADOC HEALTH, INC.: PRODUCT/SERVICE LAUNCHES,

JANUARY 2021−JANUARY 2025   376

TABLE 351            TELADOC HEALTH, INC.: DEALS, JANUARY 2021−JANUARY 2025       377

TABLE 352            GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW               378

TABLE 353            GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCTS/SERVICES OFFERED                 379

TABLE 354            GUANGDONG TRANSTEK MEDICAL ELECTRONICS CO., LTD.: PRODUCT/SERVICE LAUNCHES, JANUARY 2021−JANUARY 2025   380

LIST OF FIGURES

FIGURE 1              REMOTE PATIENT MONITORING MARKET SEGMENTATION              34

FIGURE 2              RESEARCH DESIGN         40

FIGURE 3              PRIMARY SOURCES         42

FIGURE 4              INSIGHTS FROM INDUSTRY EXPERTS     44

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,

DESIGNATION, AND REGION     44

FIGURE 6              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           45

FIGURE 7              SUPPLY-SIDE MARKET ESTIMATION      47

FIGURE 8              REMOTE PATIENT MONITORING MARKET: REVENUE ESTIMATION APPROACH         47

FIGURE 9              BOTTOM-UP APPROACH: END-USER SPENDING ON REMOTE PATIENT MONITORING     49

FIGURE 10            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)          51

FIGURE 11            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 52

FIGURE 12            TOP-DOWN APPROACH                52

FIGURE 13            DATA TRIANGULATION METHODOLOGY                 53

FIGURE 14            REMOTE PATIENT MONITORING MARKET, BY COMPONENT,

2024 VS. 2030 (USD MILLION)      56

FIGURE 15            REMOTE PATIENT MONITORING MARKET, BY INDICATION,

2024 VS. 2030 (USD MILLION)      57

FIGURE 16            REMOTE PATIENT MONITORING MARKET, BY END USER,

2024 VS. 2030 (USD MILLION)      58

FIGURE 17            REMOTE PATIENT MONITORING MARKET: GEOGRAPHIC SNAPSHOT            59

FIGURE 18            TRANSFORMATION OF PATIENT CARE THROUGH DIGITIZATION TO PROPEL MARKET                60

FIGURE 19            HEALTHCARE PROVIDERS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)                 61

FIGURE 20            EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES

DURING FORECAST PERIOD       62

FIGURE 21            EMERGING MARKETS TO GROW AT HIGHER CAGR DURING FORECAST PERIOD          62

FIGURE 22            REMOTE PATIENT MONITORING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES                 64

FIGURE 23            DIGITAL HEALTH FUNDING HISTORY, 2020−2024 (USD BILLION)           66

FIGURE 24            NUMBER OF DEALS IN DIGITAL HEALTH (2020−2024)        66

FIGURE 25            US: MEDICARE-CERTIFIED ASCS, BY STATE (AS OF SEPTEMBER 2024)     74

FIGURE 26            HEALTHCARE SECURITY BREACHES OF 500 + RECORDS, 2009–2024       75

FIGURE 27            HEALTHCARE SECURITY BREACHES, 2009–2023                 76

FIGURE 28            REMOTE PATIENT MONITORING MARKET: ECOSYSTEM ANALYSIS  80

FIGURE 29            REMOTE PATIENT MONITORING MARKET: VALUE CHAIN ANALYSIS               82

FIGURE 30            IMPORT OF PRODUCTS UNDER HSN CODE: 90189099,

BY COUNTRY, 2023 (USD THOUSAND)   97

FIGURE 31            EXPORTS OF PRODUCTS UNDER HSN CODE: 90189099,

BY COUNTRY, 2023 (USD THOUSAND)   98

FIGURE 32           IMPORT OF PRODUCTS UNDER HSN CODE: 9021,

BY COUNTRY, 2023 (USD THOUSAND)   98

FIGURE 33            EXPORTS OF PRODUCTS UNDER HSN CODE: 9021, BY COUNTRY,

2023 (USD THOUSAND) 99

FIGURE 34           IMPORT OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY,

2023 (USD THOUSAND) 99

FIGURE 35            EXPORTS OF PRODUCTS UNDER HSN CODE: 9022, BY COUNTRY,

2023 (USD THOUSAND) 100

FIGURE 36            REMOTE PATIENT MONITORING MARKET: PORTER’S FIVE FORCES ANALYSIS           103

FIGURE 37            GLOBAL PATENT PUBLICATION TRENDS IN REMOTE PATIENT MONITORING MARKET, 2015–2024     105

FIGURE 38            JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR REMOTE PATIENT MONITORING PATENTS (JANUARY 2015–NOVEMBER 2024)             106

FIGURE 39            LEADING PATENTS IN REMOTE PATIENT MONITORING MARKET

(JANUARY 2015–NOVEMBER 2024)             108

FIGURE 40            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR

REMOTE PATIENT MONITORING             109

FIGURE 41            KEY BUYING CRITERIA FOR REMOTE PATIENT MONITORING, BY COMPONENT               110

FIGURE 42            POTENTIAL OF GENERATIVE AI/AI IN REMOTE PATIENT MONITORING ACROSS INDUSTRIES    117

FIGURE 43            NEW CANCER CASES IN US, 2024                152

FIGURE 44            NORTH AMERICA: REMOTE PATIENT MONITORING MARKET SNAPSHOT         176

FIGURE 45            ASIA PACIFIC: REMOTE PATIENT MONITORING MARKET SNAPSHOT       219

FIGURE 46            REVENUE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET, 2019–2023 (USD MILLION)            275

FIGURE 47            MARKET SHARE ANALYSIS OF KEY PLAYERS IN REMOTE PATIENT MONITORING MARKET (2023)              276

FIGURE 48            REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023  280

FIGURE 49            REMOTE PATIENT MONITORING MARKET: COMPANY FOOTPRINT 281

FIGURE 50            REMOTE PATIENT MONITORING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023                 287

FIGURE 51            EV/EBITDA OF KEY VENDORS   289

FIGURE 52            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA

OF KEY VENDORS            289

FIGURE 53            REMOTE PATIENT MONITORING MARKET: BRAND/SOFTWARE

COMPARATIVE ANALYSIS            290

FIGURE 54            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)             298

FIGURE 55            OMRON CORPORATION: COMPANY SNAPSHOT (2023)    306

FIGURE 56            MEDTRONIC: COMPANY SNAPSHOT (2023)                 312

FIGURE 57            GE HEALTHCARE: COMPANY SNAPSHOT (2023)                 318

FIGURE 58            ABBOTT: COMPANY SNAPSHOT (2023)  324

FIGURE 59            ORACLE: COMPANY SNAPSHOT (2023)   329

FIGURE 60            BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023)      332

FIGURE 61            NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)             336

FIGURE 62            SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)             341

FIGURE 63            BAXTER: COMPANY SNAPSHOT (2023)   345

FIGURE 64            TELADOC HEALTH, INC.: COMPANY SNAPSHOT (2023)    375

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• 沈降シリカ市場 – 2030年までの世界予測 2025-03-07
• スマートメーター市場 – 2030年までの世界予測 2025-03-07
• 産業用計測市場 – 2030年までの世界予測 2025-03-06
• 精密ろ過膜市場- 2029年までの世界予測 2025-03-06
• グリーンテクノロジーと持続可能性市場 – 2030年までの世界予測 2025-03-06

MarketsandMarkets  出版レポート一覧